Your browser doesn't support javascript.
loading
Status Quo of Cost Estimation and Systematic Review in Pharmacy Intravenous Admixture Services in China / 中国药房
China Pharmacy ; (12): 2707-2711, 2019.
Article in Chinese | WPRIM | ID: wpr-817507
ABSTRACT
OBJECTIVE: To systematically evaluate the status quo of cost estimation in pharmacy intravenous admixture services (PIVAS), and to provide cost basis for the construction of PIVAS in China. METHODS: Retrieved from PubMed, Embase, Cochrane library, CBM, CNKI, CSJD and Wanfang database from database establishment to Jan. 2019, the studies about the status quo of cost estimation in PIVAS of China were included. The descriptive analysis was conducted for content and method of cost estimation, infection to hospital. RESULTS: A total of 17 literatures were included, involving 8 before and after control studies, 6 experience sharing studies and 3 reviews. Existing reports showed that the estimation contents and methods of PIVAS cost were roughly the same. The cost included manpower, medical and health materials, fixed asset purchase, depreciation, repair costsmedicine cost and indirect costs. At the same time, the infection to hospital were reported, such as in manpower adopting, formulating detailed management measures and systems, concurrent allocation of the same kind of drugs, shortening infusion preparation and replacement time, in order to save manpower cost. CONCLUSIONS: PIVAS cost calculation method is roughly the same in some hospitals, but there is no uniform standard. It is necessary to further improve the PIVAS cost measurement standard and provide a basis for the construction and development of PIVAS in China.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Health economic evaluation / Systematic reviews Language: Chinese Journal: China Pharmacy Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Health economic evaluation / Systematic reviews Language: Chinese Journal: China Pharmacy Year: 2019 Type: Article